Skip to main content
Search
News, Views, and Advocacy From the Oncology Nursing Society
ONS Voice Home
  • News & Views
  • Advocacy
  • Stories
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
    • News & Views
    • Latest Articles
    • Clinical Practice
    • ONS News
    • ONS Leadership
    Trending Topics
    • Treatments
    • Research
    • Safety
    • COVID-19
    • ONS Congress
    • Clinical practice
    View All Topics
    Advocacy
    • Latest Articles
    • Updates
    • Get Involved
    Stories View All
    View All
    Don’t Let Barriers Prevent You From Continuing Your Nursing Education
    Nurse empowerment
    Don’t Let Barriers Prevent You From Continuing Your Nursing Education
    July 03, 2020
    Nurses Have a Role and Responsibility in Ending Racism
    Patient advocacy
    Nurses Have a Role and Responsibility in Ending Racism
    June 26, 2020
    Oncology Nurses Have a Special Power of Presence
    Oncology nurse-patient relationship
    Oncology Nurses Have a Special Power of Presence
    June 19, 2020
    Virtual Care for Patients With Cancer in New Jersey During COVID-19
    COVID-19
    Virtual Care for Patients With Cancer in New Jersey During COVID-19
    June 08, 2020
    How Nurses Can ‘Curb the Spread’ and Support Themselves
    COVID-19
    How Nurses Can ‘Curb the Spread’ and Support Themselves
    June 05, 2020
    previous slide
    next slide
    Search
  • News & Views
  • Advocacy
  • Stories
    • Home

    Author Content

    APRNs Must Stay Educated About Medical Cannabis in Cancer Care
    Advanced practice nursing (APN)

    APRNs Must Stay Educated About Medical Cannabis in Cancer Care

    As more U.S. states approve the use of medical cannabis, oncology advanced practice RNs (APRNs) may see increasing inquiries from patients who are interested in using it to manage cancer-related symptoms. However, the drug remains illegal under federal law, confounding research efforts for its use in cancer care and limiting the generation of supportive evidence.

    July 25, 2018
    CDK 4/6 Adverse Events
    Adverse events

    The Case of the CTCAE Assessment for CDK4/6 Adverse Events

    Mrs. Jones is a 66-year-old postmenopausal woman who developed left breast pain and a palpable mass. A mammogram and ultrasound showed a 4.6 cm mass with an enlarged axillary node. A core biopsy revealed invasive ductal carcinoma that is estrogen receptor positive, progesterone receptor positive, and HER2 negative. Positron-emission tomography and computed tomography scans revealed metastatic disease.

    June 19, 2018
    APRNs Can Help Address Global Financial Toxicity
    Advanced practice nursing (APN)

    APRNs Can Help Address Global Financial Toxicity

    Advancements in oncology, such as new diagnostic tools and novel therapies, have improved overall survival rates but have come at a high cost. In 2011, targeted therapies accounted for 63% of all chemotherapy expenditures. A novel cancer drug routinely costs each patient more than $100,000 per year; annual spending on cancer drugs is globally estimated around $100 billion U.S. dollars and is predicted to rise to $150 billion by 2020.

    June 14, 2018
    Stay Current on Evolving Therapies in Melanoma
    Advanced practice nursing (APN)

    Stay Current on Evolving Therapies in Melanoma

    After decades of no new treatment options for advanced melanoma, several drugs for unresectable stage III and IV disease and recurrent melanoma have been approved, including newer classes of drugs such as checkpoint inhibitors (anti-PD-1 and anti-CTLA-4 drugs) and signal transduction inhibitors (BRAF, MEK, and KIT inhibitors). Advanced practice registered nurses (APRNs) must be familiar with these newer agents and classes of drugs, especially the mutations that guide their use.

    May 10, 2018
    The Case of the Checkpoint Inhibitor Side Effects
    Immunotherapy

    The Case of the Checkpoint Inhibitor Side Effects

    John is a 62-year-old man diagnosed with metastatic non-small cell lung cancer (NSCLC). His tumor tested positive for high PD-L1 expression, and he began pembrolizumab treatment. John presents to the clinic for his third treatment and mentions that during the past week his arms and chest have been itchy and he has noticed a red, bumpy rash on his chest. When assessing John’s skin, you note a maculopapular rash on both of his upper extremities, anterior chest, and upper abdomen. What would you do?

    April 17, 2018
    Managing Weight Loss in Patients With Cancer
    Advanced practice nursing (APN)

    Managing Weight Loss in Patients With Cancer

    Patients’ weight and nutrition status will often vary throughout the cancer care continuum. Weight loss might occur before the diagnosis, be one of the presenting cancer symptoms, be related to the tumor itself, or be secondary to side effects of their treatment (e.g., anorexia from chemotherapy or radiation). 

    March 27, 2018
    The Case of the Cancer Genetics Referral
    Clinical practice

    The Case of the Cancer Genetics Referral

    Christina is a 29-year-old African American woman with a strong family history of breast and ovarian cancers and a personal history of benign ovarian fibroids. She was referred to your office because of a suspicious lump in her left breast. Because of her family history, Christina is especially worried. You are concerned that Christina could have a hereditary family cancer syndrome, and you know that a comprehensive family history must be obtained.

    February 19, 2018
    Prevent and Treat Venous Thromboembolism in Patients With Cancer
    Clinical practice

    Prevent and Treat Venous Thromboembolism in Patients With Cancer

    Venous thromboembolism (VTE), namely deep vein thrombosis and pulmonary embolism, is a common and serious complication. VTE is the second-leading cause of death in patients with cancer and has been connected to poorer prognoses. Other consequences include reduced short- and long-term mortality, increased risk for recurrent VTE and bleeding, a threefold increase in hospitalizations, and higher total healthcare costs. Advance practice nurses (APNs) must understand prevention strategies and treatment guidelines for this serious complication.  

    February 17, 2018
     
    Kristen Baileys, RN, MSN, CRNP, OCN®
    Home
    News, Views, and Advocacy From the Oncology Nursing Society
  • Legal Notices
  • Contact Us
  • Conferences
  • Advertising
  • Newsroom
  • Sitemap

  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • ONS
  • Oncology Nursing Foundation
  • ONCC
    • © Copyright 2020 Oncology Nursing Society
     
    Back to Top ▲